Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
BRDS
|
David O Sacks
Director |
BUY
Grant, award, or other acquisition
|
Direct | 33,639 Added 50.0% |
-
|
Feb 25
2022 |
|
ZY
|
Zachariah Serber
Director |
SELL
Open market or private sale
|
Direct | 4,011 Reduced 0.17% |
$15,683
$3.91 p/Share
|
Feb 25
2022 |
|
JAKK
|
Lawrence I Rosen
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 29,221 Added 1.62% |
$436,854
$14.95 p/Share
|
Feb 25
2022 |
|
APRN
|
Linda Findley
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 16,090 Added 9.91% |
-
|
Feb 25
2022 |
|
APRN
|
Meredith L Deutsch
General Counsel & Corp. Sec'y |
BUY
Exercise of conversion of derivative security
|
Direct | 4,786 Added 15.41% |
-
|
Feb 25
2022 |
|
APRN
|
Randy J Greben
CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct | 15,300 Added 50.0% |
-
|
Feb 25
2022 |
|
APRN
|
Charlean Gmunder
Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 4,614 Added 22.05% |
-
|
Feb 25
2022 |
|
APRN
|
Danielle Simpson
Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,393 Added 15.43% |
-
|
Feb 25
2022 |
|
APRN
|
Irina Krechmer
Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 6,744 Added 14.28% |
-
|
Feb 25
2022 |
|
SNDA
|
Michael Fryar
SVP-Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 70 Reduced 0.19% |
$2,331
$33.3 p/Share
|
Feb 25
2022 |
|
VIRX
|
Daniel R. Chevallard
CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct | 6,889 Added 7.94% |
-
|
Feb 25
2022 |
|
VIRX
|
Roger Pomerantz |
BUY
Exercise of conversion of derivative security
|
Direct | 9,034 Added 25.0% |
-
|
Feb 25
2022 |
|
VIRX
|
Lisa Rojkjaer
Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 4,127 Added 8.83% |
-
|
Feb 25
2022 |
|
VIRX
|
Ivor Royston |
BUY
Exercise of conversion of derivative security
|
Direct | 25,219 Added 4.01% |
-
|
Feb 25
2022 |
|
APEN
|
Mike Gutteridge
VP, Int'l Sales and Marketing |
BUY
Grant, award, or other acquisition
|
Direct | 22,610 Added 26.16% |
-
|
Feb 25
2022 |
|
APEN
|
Jeffrey G. Black
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 15,000 Added 5.88% |
$82,200
$5.48 p/Share
|
Feb 25
2022 |
|
HYFM
|
Bruce John Lindeman
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 10,000 Added 2.99% |
$204,000
$20.4 p/Share
|
Feb 25
2022 |
|
ALLK
|
Adam Tomasi
President |
BUY
Grant, award, or other acquisition
|
Direct | 344,060 Added 37.45% |
-
|
Feb 25
2022 |
|
ALLK
|
Harlan Baird Radford
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 237,608 Added 46.0% |
-
|
Feb 25
2022 |
|
ALLK
|
Mark Asbury
CLO |
BUY
Grant, award, or other acquisition
|
Direct | 140,490 Added 38.06% |
-
|
Feb 25
2022 |
|
ALLK
|
Robert Alexander
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 529,323 Added 39.97% |
-
|
Feb 25
2022 |
|
OSG
|
Richard Trueblood
VP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 3,773 Reduced 2.61% |
$7,244
$1.92 p/Share
|
Feb 25
2022 |
|
OSG
|
Richard Trueblood
VP & CFO |
BUY
Grant, award, or other acquisition
|
Direct | 15,492 Added 9.67% |
-
|
Feb 25
2022 |
|
OSG
|
Patrick Joseph O'Halloran
VP & Chief Operations Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,314 Reduced 2.19% |
$6,363
$1.92 p/Share
|
Feb 25
2022 |
|
OSG
|
Patrick Joseph O'Halloran
VP & Chief Operations Officer |
BUY
Grant, award, or other acquisition
|
Direct | 13,609 Added 8.27% |
-
|
Feb 25
2022 |
|
OSG
|
Samuel H Norton
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 11,134 Reduced 0.62% |
$21,377
$1.92 p/Share
|
Feb 25
2022 |
|
OSG
|
Samuel H Norton
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 45,724 Added 2.5% |
-
|
Feb 25
2022 |
|
OSG
|
Damon Mote
VP & Chief Admin Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,314 Reduced 2.2% |
$6,363
$1.92 p/Share
|
Feb 25
2022 |
|
OSG
|
Damon Mote
VP & Chief Admin Officer |
BUY
Grant, award, or other acquisition
|
Direct | 13,609 Added 8.27% |
-
|
Feb 25
2022 |
|
OSG
|
Susan Allan
VP, General Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct | 3,341 Reduced 2.65% |
$6,415
$1.92 p/Share
|
Feb 25
2022 |
|
OSG
|
Susan Allan
VP, General Counsel & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct | 13,717 Added 9.81% |
-
|
Feb 25
2022 |
|
LTRX
|
Hoshi Printer
Director |
SELL
Open market or private sale
|
Direct | 12,026 Reduced 8.2% |
$82,138
$6.83 p/Share
|
Feb 25
2022 |
|
LTRX
|
Hoshi Printer
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 50,000 Added 25.43% |
$82,500
$1.65 p/Share
|
Feb 25
2022 |
|
FATH
|
Ryan Martin
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 50,619 Added 2.93% |
-
|
Feb 25
2022 |
|
FATH
|
Mark T Frost
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 33,746 Added 7.16% |
-
|
Feb 25
2022 |
|
FATH
|
Richard L. Stump
Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 33,746 Added 5.53% |
-
|
Feb 25
2022 |
|
MIXT
|
Ian Jacobs
Director |
BUY
Open market or private purchase
|
Indirect | 1,207,750 Added 7.69% |
$555,565
$0.46 p/Share
|
Feb 25
2022 |
|
CPSS
|
Teri Robinson
Exec. Vice President |
SELL
Open market or private sale
|
Direct | 1,432 Reduced 0.39% |
$17,184
$12.0 p/Share
|
Feb 25
2022 |
|
CPSS
|
Chris Terry
Exec. Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 37,721 Reduced 36.76% |
$452,652
$12.0 p/Share
|
Feb 25
2022 |
|
CPSS
|
Chris Terry
Exec. Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 60,000 Added 36.9% |
$366,600
$6.11 p/Share
|
Feb 25
2022 |
|
SKYT
|
Thomas Sonderman
CEO |
BUY
Grant, award, or other acquisition
|
Direct | 44,483 Added 7.51% |
-
|
Feb 25
2022 |
|
SKYT
|
Steve Manko
CFO |
BUY
Grant, award, or other acquisition
|
Direct | 21,018 Added 4.02% |
-
|
Feb 25
2022 |
|
SKYT
|
Nancy Fares
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,631 Added 50.0% |
-
|
Feb 25
2022 |
|
SKYT
|
Chunyi (Amy) Leong
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,631 Added 50.0% |
-
|
Feb 25
2022 |
|
BWFG
|
Lawrence B Seidman
Director |
BUY
Open market or private purchase
|
Direct | 143 Added 6.29% |
$4,995
$34.93 p/Share
|
Feb 25
2022 |
|
BWFG
|
James M Garnett Jr
Director |
BUY
Open market or private purchase
|
Direct | 117 Added 6.44% |
$4,087
$34.93 p/Share
|
Feb 25
2022 |
|
APEI
|
Thomas Beckett
SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 416 Reduced 1.33% |
$8,228
$19.78 p/Share
|
Feb 25
2022 |
|
APEI
|
Thomas Beckett
SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 4,142 Added 11.71% |
-
|
Feb 25
2022 |
|
APEI
|
Patrik Dyberg
Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 688 Reduced 1.29% |
$13,609
$19.78 p/Share
|
Feb 25
2022 |
|
APEI
|
Patrik Dyberg
Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct | 6,850 Added 11.34% |
-
|
Feb 25
2022 |